US FDA approves Tasigna® for treatment of Philadelphia chromosome-positive chronic myeloid leukemiaExpert Review of Pharmacoeconomics & Outcomes Research 7(6):p 540-541, December 2007.Copyright © © 2007Expert Reviews, Ltd.
